Literature DB >> 15637440

Mechanism of VEGF-induced uterine venous hyperpermeability.

Gerard Celia1, George Osol.   

Abstract

BACKGROUND: Transfer of molecular signals from veins to adjacent arteries is an established mechanism of vascular communication in the uterine circulation, which ultimately depends on venous permeability. This study tests the hypotheses that: (1) uterine veins are permeable to intravenous solutes, using a 3-kDa dextran tracer and (2) this permeability is enhanced in response to vascular endothelial growth factor (VEGF). Additionally, the involvement of nitric oxide (NO), calcium, and the phospholipase C-protein kinase C (PLC-PKC) cascade in VEGF-enhanced permeability were investigated, and the impact of pregnancy-induced uterine vascular remodeling on permeability was evaluated.
METHODS: Studies utilized fluorimetry to quantitate solute flux in isolated segments of rat uterine vein as a function of endothelial surface area and time under basal and VEGF-stimulated conditions. VEGF signaling was probed using NO synthase inhibition (L-NNA), calcium channel blockade (lanthanum chloride) and withdrawal (calcium-free solution), and inhibitors of the PLC-PKC cascade (U-73122 and chelerythrine chloride, respectively). Gestational effects were assessed using vessels from late pregnant (day 20) rats.
RESULTS: Basal flux (control) in nonpregnant animals was 26 +/- 2.5 molecules/microm2/min x 1,000 and was increased significantly by VEGF in a concentration-dependent manner (1 nM approximately 3.3-fold, 10 nM approximately 4.6-fold). Inhibition of PLC, PKC, and calcium signaling, but not NO, attenuated the response to VEGF. Gestation significantly increased flux (78 +/- 9.3 molecules/microm2/min x 1,000), and maintained responsiveness to VEGF.
CONCLUSIONS: These results demonstrate uterine venous permeability to intermediate-sized solutes through a VEGF-sensitive pathway involving calcium and PLC-PKC, but not NO, and further substantiate a role for veno-arterial communication in uterine blood flow regulation during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15637440     DOI: 10.1159/000082976

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  7 in total

Review 1.  Plasticity of the Maternal Vasculature During Pregnancy.

Authors:  George Osol; Nga Ling Ko; Maurizio Mandalà
Journal:  Annu Rev Physiol       Date:  2019-02-10       Impact factor: 19.318

2.  The adaptation of the blood-brain barrier to vascular endothelial growth factor and placental growth factor during pregnancy.

Authors:  Malou P H Schreurs; Emily M Houston; Victor May; Marilyn J Cipolla
Journal:  FASEB J       Date:  2011-09-12       Impact factor: 5.191

3.  Downstream exposure to growth factors causes elevated velocity and dilation in arteriolar networks.

Authors:  Melissa K Georgi; Anthony M Dewar; Mary D Frame
Journal:  J Vasc Res       Date:  2010-07-06       Impact factor: 1.934

Review 4.  The adaptation of the cerebral circulation to pregnancy: mechanisms and consequences.

Authors:  Marilyn J Cipolla
Journal:  J Cereb Blood Flow Metab       Date:  2013-01-16       Impact factor: 6.200

5.  Placental growth factor is a potent vasodilator of rat and human resistance arteries.

Authors:  George Osol; Gerard Celia; Natalia Gokina; Carolyn Barron; Edward Chien; Maurizio Mandala; Leonid Luksha; Karolina Kublickiene
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-01-11       Impact factor: 4.733

6.  Predominance of local over systemic factors in uterine arterial remodeling during pregnancy.

Authors:  Robert Fuller; Carolyn Barron; Maurizio Mandala; Natalia Gokina; George Osol
Journal:  Reprod Sci       Date:  2009-01-22       Impact factor: 3.060

7.  Delineation of VEGF-regulated genes and functions in the cervix of pregnant rodents by DNA microarray analysis.

Authors:  Chishimba N Mowa; Tianbo Li; Subrina Jesmin; Hans G Folkesson; Sharon E Usip; Raymond E Papka; Guichuan Hou
Journal:  Reprod Biol Endocrinol       Date:  2008-12-16       Impact factor: 5.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.